期刊文献+

微小RNA-7对人视网膜色素上皮细胞增生和迁移的影响 被引量:4

Effects of microRNA-7 on proliferation and migration of human retinal pigment epithelial cells
下载PDF
导出
摘要 目的探讨微小RNA-7(miRNA-7)对人视网膜色素上皮(human retinal pigment epithelium,hRPE)细胞增生和迁移的调控作用。方法利用脂质体Lipofectamine 2000将miRNA-7前体miRNA-145(miRNA-7前体干预组)和阴性对照物(阴性miRNA对照组)转染hRPE细胞,同时设立空脂质体组和空白对照组,采用Real-Time PCR检测成熟miRNA-7的表达,CCK-8检测细胞增殖抑制情况,用直径为8.5 mm的Boyden小室进行细胞迁移能力的检测,对4组结果作统计学分析。结果 miRNA-7对hRPE细胞增殖有明显抑制作用,miRNA-7前体干预组细胞增殖抑制率(23.58%)明显高于阴性miRNA对照组(2.35%)、空脂质体组(2.97%)与空白对照组(0%),差异均具有统计学意义(均为P<0.05),空脂质体组、阴性miRNA对照组与空白对照组之间差异均无统计学意义(均为P>0.05)。在miRNA-7前体干预组中,迁移细胞数明显较少,每高倍视野为(16.0±3.8)个,而在阴性miRNA对照组、空脂质体组和空白对照组中,迁移细胞数明显较多,每高倍视野分别为(32.2±7.8)个、(31.4±6.9)个和(33.9±8.4)个,miRNA-7前体干预组细胞迁移数较后3组显著减少,差异均有统计学意义(均为P<0.01),而后3组之间差异均无统计学意义(均为P>0.05)。结论 miRNA-7可明显抑制hRPE细胞的增殖和迁移,这种抑制作用可能是由于miRNA-7对hRPE细胞的EGFR通路产生了良好的靶向沉默后效应,直接下调EGFR表达,从而阻断或部分阻断了ERK1/2信号通路,使得hRPE细胞的增殖和迁移受到明显抑制。 Objective To evaluate the regulation function of microRNA-7 on pro- liferation and migration of human retinal pigment epithelial ( hRPE ) cells. Methods Using liposomes Lipofectamine2000 transmit microRNA-7 precursor (transfection group) and negative control ( control group) into hRPE cells, then the expression of ma- ture microRNA-7 was detected by RT-PCR, cell proliferative inhibition was detected by CCK 8, and cell migration ability was investigated with a diameter of 8.5 mm Boyden chamber. Results In the transfection group, blank control group, empty liposome group and negative control group, hRPE cell proliferation was significantly inhibited by microRNA-7, the proliferative inhibition rate of transfection group (23.58%)was signifi- cantly higher than that of negative control group (2. 35% ), empty liposome group (2. 97% )and blank control group (0%), there were statistical differences between these groups ( all P 〈 0.05 ), no statistical difference between empty liposome group, negative control group and blank control group ( all P 〉 0.05 ). In microRNA-7 transfec- tion group, microRNA-7 inhibited RPE cell migration obviously, compared with the other three groups the cells of migration ( 16.0 ±3.8 ) were significantly reduced ( all P 〈0. 01 ). In the negative control group, empty liposome group and blank control group, the number of migrating cells were 32.2 ±7.8,31.4 ±5.9 and 5.9 ±8.4, respectively, and there was no statistical difference between three groups ( all P 〉 0. 05). Conclusion MicroRNA-7 can inhibit the proliferation and migration of hRPE cells obviously, which may be the gene silencing after-effects targeting EGFR pathway ( RPE cells response gene) to reduce EGFR expression directly with block or partially blocked ERK1/2 signaling pathways.
出处 《眼科新进展》 CAS 北大核心 2014年第2期122-126,共5页 Recent Advances in Ophthalmology
基金 广州市番禺区科技计划项目(编号:2011-Z-03-23)~~
关键词 视网膜色素上皮细胞 增生性玻璃体视网膜病变 表皮生长因子受体 微小RNA retinal pigment epithelial cell proliferative vitreoretinopathy epidermal growth factor microRNA
  • 相关文献

参考文献15

  • 1李林,李斌,杨安怀,赵婷秀,邢怡桥.人视网膜下膜中ICAM-1及MMP-2的免疫组织化学研究[J].眼科新进展,2005,25(6):519-521. 被引量:3
  • 2Yano S, Kondo K, Yamaguchi M, Richmond G, Hutchison M, Wakeling A, et al. Distribution and function of EGFR in human tissue and the effect of EGFR tyrosine kinase inhibition[ J]. An- ticancer Res ,2003,23 (5) :3639-3650.
  • 3李晓梅,刘建红,吕欣,李晓莺,刘向红,胡伟,段春红,牟鸿,蒋芙蓉,张兆芳.胃肠功能障碍早产儿胃液表皮生长因子水平变化及意义[J].实用儿科临床杂志,2012,27(6):424-426. 被引量:6
  • 4郑翠侠,韩兵,周翔,张荣新,万欢英,臧旺福,陈中元.非小细胞肺癌中表皮生长因子受体基因突变的筛查[J].新乡医学院学报,2011,28(2):190-192. 被引量:3
  • 5张惠蓉,曹景泰,刘宁朴,贺师鹏.视网膜增殖性疾病玻璃体中表皮生长因子的放射受体定量测定[J].中华眼底病杂志,1996,12(2):91-93. 被引量:12
  • 6Lewis TS, Shapiro PS ,Ahn NG. Signal transduction through MAP kinase cascades[ J]. Adv Cancer Res,1998,74( 1 ) :49-139.
  • 7Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function [ J ]. Cell, 2004,116 ( 2 ) : 281-297.
  • 8Griffiths-Jones S, Grocock R J, van Dongen S, Bateman A, En- right A. miRBase: microRNA sequences, targets and gene no- menclature [ J ]. Nucleic Acids Res, 2005,34 ( 1 ) : 140-144.
  • 9Arora A, McKay G J, Simpson DA. Prediction and verification of miRNA expression in human and rat retinasE J]. Invest Ophthal- mol Vis Sci,2007,48 (9) :3962-3957.
  • 10Bravo-Egana V, Rosero S, Molano RD, Pileggi A, Ricordi C, Domlngnez-Bendala J. et al. Quantitative differential expression analysis reveals miR-7 as major islet microRNA [ J ]. Biochem Biophys Res Commun,2008,355 (4) :922-925.

二级参考文献30

  • 1贺师鹏,黄天贵,黄力新,郭淑英.放射受体法测定表皮生长因子[J].生物化学与生物物理进展,1993,20(3):220-222. 被引量:5
  • 2曹景泰,武丽,张惠蓉,刘宁朴,贺师鹏,陈非.视网膜增殖性疾病玻璃体中胰岛素样生长因子的放射免疫测定[J].中华眼科杂志,1995,31(2):122-125. 被引量:10
  • 3李小燕.小儿多脏器功能障碍时急性胃肠功能障碍临床分析[J].中国现代医药杂志,2006,8(10):46-48. 被引量:1
  • 4Hommel KA,Mcgraw KL,Ammerman RT,et al.Psychosocial functio-ning in children and adolescents with gastrointestinal complaints and di-sorders[J].J Clin Psychol Med Settings,2010,17(2):159-166.
  • 5Visentin M,Biason P,Toffoli G.Drug interactions among the epidermalgrowth factor receptor inhibitors,other biologics and cytotoxic agents[J].Pharmacol Ther,2010,128(1):82-90.
  • 6Zhou Y,Brigstock D,Besner GE.Heparin-binding EGF-likegrowth factor is a potent dilator of terminal mesenteric arterioles[J].Microvasc Res,2009,78(1):78-85.
  • 7Dvorak B.Milk epidermal growth factor and gut protection[J].J Pe-diatr,2010,156(suppl 2):31-35.
  • 8Rocourt DV,Mehta VB,Wu D,et al.Heparin-binding EGF-likegrowth factor decreases neutrophil-endothelial cell interactions[J].JSurg Res,2007,141(2):262-266.
  • 9Cheung WY,Zhai R,Kulke MH,et al.Epidermal growth factorA61G gene polymorphism,gastroesophageal reflux disease and esopha-geal adenocarcinoma risk[J].Carcinogenesis,2009,30(8):1363-1367.
  • 10Nair RR,Warner BB,Warner BW.Role of epidermal growth factorand other growth factors in the prevention of necrotizing enterocolitis[J].Semin Perinatol,2008,32(2):107-113.

共引文献20

同被引文献29

  • 1许迅,王方,胡宏慧,王裕发,张皙,何志平.PDGF受体、TGF-β_1及其受体在视网膜下液中的表达[J].眼科新进展,2002,22(1):9-11. 被引量:2
  • 2He S, Kumar SR, Zhou P, et al. Soluble EphB4 inhibition of PDGF- induced RPE migration in vitro [J]. Invest Ophthalmol Vis Sci, 2010,51(1) :543-552.
  • 3Jing Cui, Hetian Lei, Arif Samad, et al. PDGF Receptors Are Activated in Human Epiretinal Membranes[J]. Exp Eye Res, 2009,88(3) : 438-444.
  • 4Johnsen EO, Froen RC, Albert R,et al. Activation of neuralprogenitor cells in human eyes with proliferative vitreoretinopathy [J ]. Exp Eye Res, 2012,98 ( 1 ) : 28-36.
  • 5Nassar K, Luke J, Luke M, et al. The novel use of decorin in prevention of the development of proliferative vitreoretinopathy (PVR). Graefes Arch Clin Exp Ophthalmol 2011 ; 24-49 ( 11 ) : 1649-1660.
  • 6Kita T. Molecular mechanisms of preretinal membrane contraction in proliferative vitreoretinal diseases and ROCK as a therapeutic target. Nihon Ganka Gakkai Zasshi 2010 ; 114 ( 11 ) :927-934.
  • 7Umazume K, Tsukahara R, Liu L, et al. Role of retinal pigment epi- thelial cell β-catenin signaling in experimental proliferative vitreo- retinopathy [ J ]. Am J Patho1,2014,184 ( 5 ) : 1419 - 28.
  • 8Lei H, Rheaume M A, Kazlauskas A, et al. Recent developments in our understanding of how platelet-derived growth factor (PDGF) and its receptors contribute to proliferative vitreoretinopathy - J 1. Exp Eye Res,2010,90(3) :376 -81.
  • 9Lei H, Rheaume M A,Velez G, et al. Expression of PDGFR-a is a determinant of the PVR potential of ARPE-19 cells [J]. Invest Ophthalmol Vis Sci,2011,52 (9) :5016 - 21.
  • 10Carrington L, McLeod D, BouLton M. IL-10 and antibodies to TGF-beta2 and PDGF inhibit RPE-mediated retinal contraction [ J ]. Invest Ophthalmol Vis Sci, 2000,41 ( 5 ) : 1210 - 16.

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部